Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

New research has uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often ...

New research recommends that clinicians screen for foot peripheral sensory neuropathy during initial assessments for patients with systemic sclerosis.

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving ...

Chemomab Therapeutics (CMMB) announced a new scientific presentation that further confirms the potential of nebokitug as a novel treatment for ...

Adds to Extensive Preclinical and Early Clinical Evidence that Nebokitug Interferes with Key Features of Systemic Sclerosis TEL AVIV, Israel, March 06, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, ...